Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cashflow Statement

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹1,055 Cr₹1,619 Cr₹1,335 Cr₹993 Cr
Adjustment ₹38 Cr₹-28 Cr₹17 Cr₹32 Cr
Changes In working Capital ₹-418 Cr₹-393 Cr₹-436 Cr₹-80 Cr
Cash Flow after changes in Working Capital ₹675 Cr₹1,197 Cr₹916 Cr₹945 Cr
Cash Flow from Operating Activities ₹364 Cr₹791 Cr₹605 Cr₹701 Cr
Cash Flow from Investing Activities ₹1,208 Cr₹-1,003 Cr₹-1,524 Cr₹-766 Cr
Cash Flow from Financing Activities ₹15 Cr₹35 Cr₹1,238 Cr₹-6.87 Cr
Net Cash Inflow / Outflow ₹1,587 Cr₹-177 Cr₹319 Cr₹-72 Cr
Opening Cash & Cash Equivalents ₹319 Cr₹492 Cr₹169 Cr₹236 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ----
Cash & Cash Equivalent of Subsidiaries under liquidations ----
Translation adjustment on reserves / op cash balalces frgn subsidiaries ----
Effect of Foreign Exchange Fluctuations ₹3.00 Cr₹3.31 Cr₹3.58 Cr₹5.11 Cr
Closing Cash & Cash Equivalent ₹1,909 Cr₹319 Cr₹492 Cr₹169 Cr

Compare Cashflow Statement of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,477.5 Cr -2.7% -3.7% 32.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,920.0 Cr -2.3% -6.5% 55.3% Stock Analytics
CIPLA ₹113,794.0 Cr 4.1% -4.8% 55.6% Stock Analytics
DIVIS LABORATORIES ₹106,860.0 Cr 7.8% 17.4% 20.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,316.0 Cr 4% 0.8% 29.4% Stock Analytics
ZYDUS LIFESCIENCES ₹95,380.9 Cr -1.2% -5.2% 83.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.7%

-3.7%

32.7%

SENSEX

0.9%

1.5%

23.6%


You may also like the below Video Courses